Patents by Inventor Shaswath Chandrasekar

Shaswath Chandrasekar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240091349
    Abstract: Quil-A chitosan spherical nanostructure complexes as well as methods of making and using such complexes are disclosed herein. Also provided are Quil-A chitosan spherical nanostrucutres loaded with one or more RNA, DNA, or protein payload molecules as well as methods of making and using such loaded complexes.
    Type: Application
    Filed: August 16, 2023
    Publication date: March 21, 2024
    Inventors: Adel M. Talaat, Shaswath Chandrasekar
  • Patent number: 11771761
    Abstract: Quil-A chitosan spherical nanostructure complexes as well as methods of making and using such complexes are disclosed herein. Also provided are Quil-A chitosan spherical nanostrucutres loaded with one or more RNA, DNA, or protein payload molecules as well as methods of making and using such loaded complexes.
    Type: Grant
    Filed: June 12, 2020
    Date of Patent: October 3, 2023
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Adel M. Talaat, Shaswath Chandrasekar
  • Publication number: 20230158138
    Abstract: The present invention provides both QuilA-loaded chitosan (QAC)-encapsulated NA vaccine compositions and viral vaccine compositions that encode an Infectious Bronchitis Virus (IBV) spike (S) protein, an IBV nucleocapsid (N) protein, or both the S protein and the N protein. Additionally, the present invention provides methods in which the disclosed vaccines are administered to a subject to induce an immune response against IBV or to vaccinate the subject against IBV.
    Type: Application
    Filed: November 23, 2022
    Publication date: May 25, 2023
    Inventors: Adel Talaat, Shaswath Chandrasekar
  • Publication number: 20220160822
    Abstract: The present invention provides both QuilA-loaded chitosan (QAC)-encapsulated DNA vaccine compositions and viral vaccine compositions that encode a SARs-CoV-2 spike (S) protein, a SARs-CoV-2 nucleocapsid (N) protein, or both the S protein and the N protein. Additionally, the present invention provides methods in which the disclosed vaccines are administered to a subject to induce an immune response against SARS-CoV-2.
    Type: Application
    Filed: November 23, 2021
    Publication date: May 26, 2022
    Inventors: Adel M. Talaat, Shaswath Chandrasekar
  • Publication number: 20200390883
    Abstract: Quil-A chitosan spherical nanostructure complexes as well as methods of making and using such complexes are disclosed herein. Also provided are Quil-A chitosan spherical nanostructures loaded with one or more RNA, DNA, or protein payload molecules as well as methods of making and using such loaded complexes.
    Type: Application
    Filed: June 12, 2020
    Publication date: December 17, 2020
    Inventors: Adel M. Talaat, Shaswath Chandrasekar